Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New launch for Arimidex

Sep. 20, 1996

Taxotere-doxorubicin com0bination as first-line treatment of advanced breast cancer

Sep. 20, 1996

CI-958 for treatment of prostate cancer

Sep. 20, 1996

XR-5000 advances through clinical trials

Sep. 20, 1996

Further approval recommended for Novantrone

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

Daiichi's anticancer drugs in development

Sep. 13, 1996

Chugai's anticancer R&D pipeline

Sep. 13, 1996

Expanded approval sought for Photofrin

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...